Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04623216 |
| Title | Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation. |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | ITA | FRA | ESP | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Marseille | 13273 | France | Details | ||
| Novartis Investigative Site | Freiburg | 79106 | Germany | Details | ||
| Novartis Investigative Site | Hamburg | 20246 | Germany | Details | ||
| Novartis Investigative Site | Muenster | 48149 | Germany | Details | ||
| Novartis Investigative Site | Bergamo | BG | 24127 | Italy | Details | |
| Novartis Investigative Site | Bologna | BO | 40138 | Italy | Details | |
| Novartis Investigative Site | Brescia | BS | 25123 | Italy | Details | |
| Novartis Investigative Site | Roma | RM | 00165 | Italy | Details | |
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details |